Artificial heart offers hope for transplant candidates
Disease control
Ongoing
This study is testing a total artificial heart (Carmat TAH) in 104 people with severe, irreversible heart failure who are waiting for a heart transplant. The goal is to see if the device can keep them alive and well without major complications like disabling stroke or device fail…
Phase: NA • Sponsor: Carmat SAS • Aim: Disease control
Last updated May 17, 2026 13:59 UTC